Compugen (CGEN) Cash & Equivalents Growth (1y) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 396.99% |
| Sep 30, 2025 | 3.31% |
| Jun 30, 2025 | -45.55% |
| Dec 31, 2024 | 31.24% |
| Jun 30, 2024 | -30.43% |
| Dec 31, 2023 | 25.60% |
| Jun 30, 2023 | 103.93% |
| Dec 31, 2022 | 41.76% |
| Jun 30, 2022 | 6.68% |
| Dec 31, 2021 | 9.21% |
| Jun 30, 2021 | -37.17% |
| Dec 31, 2020 | -22.25% |
| Jun 30, 2020 | 100.51% |
| Dec 31, 2019 | 42.08% |
| Jun 30, 2019 | -43.06% |
| Dec 31, 2018 | -74.61% |
| Jun 30, 2018 | -35.33% |
| Dec 31, 2017 | 162.33% |
| Jun 30, 2017 | 56.95% |
| Dec 31, 2016 | -9.91% |
| Jun 30, 2016 | -57.97% |
| Dec 31, 2015 | -57.97% |
| Jun 30, 2015 | -10.81% |
| Dec 31, 2014 | -10.81% |
| Jun 30, 2014 | 119.57% |
| Dec 31, 2013 | 75.59% |
| Jun 30, 2013 | 49.02% |
| Dec 31, 2012 | 180.09% |
| Jun 30, 2012 | 20.37% |
| Dec 31, 2011 | -19.92% |
| Jun 30, 2011 | -51.78% |
| Dec 31, 2010 | -51.78% |
| Sep 30, 2010 | -8.04% |
| Jun 30, 2010 | 225.57% |